In vitro and in vivo evaluation of stimuli sensitive hydrogel for ophthalmic drug delivery

Indian Journal of Pharmaceutical Education and Research

Volumn 44, Issue 4, 2010, Pages 380-385

  Singh, Vinod ^a   Busheetti, S S ^b   Raju, S Appala ^c   Ahmad, Rizwan ^b   Singh, Mamta ^b  

^a Luqman College of Pharmacy   (India)

^b Sardar Bhagwan Singh Post Gratudate Institute of Biomedical Sciences & Research   (India)

^c HKE's College of Pharmacy   (India)

Author keywords

Carbopols; Stimuli sensitive hydrogels; Timolol maleate; Viscosity

Indexed keywords

EYE DROPS; TIMOLOL MALEATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; EYE IRRITATION; FEMALE; GLAUCOMA; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; MALE; MEAN RESIDENCE TIME; NONHUMAN; PH; PHASE TRANSITION; RABBIT; VISCOSITY;

EID: 78249263507     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bushetti SS, Vinod Singh, Appala Raju S, AtharJaved, Veermaram. Stimuli Sensitive hydrogels: A review. Indian J Pharm Educ Res 2009; 43(3):10-19
2. Garway- Health DF, Rudnicka AR, Lowe T. Measurment of optic disk size: Equivalence of methods to correct for ocular magnification. Br J Ophthalmol 1998; 82: 643-649.
3. Thylefors B, Negrel AD. The global impact of glaucoma. Bull world health organ 1994; 72: 323-326.
4. Maurice D.M., kinetics of topical applied drugs, In:saettone,M.S, bucci,p, speiserp (eds).ophthalmicdrugdelivery, biopharmaceutical, technological and clinical aspects. fidia research series vol.11.Padova: liviana press;1987.19-26.
5. Alfanso R G. Ophthalmic preparation: Remington pharmaceutical sciences. 18 th edition. Pennsylvania: Mackpublishing company;1990;1581
6. Ding. Recent development in ophthalmic drug delivery. Pharm. Sci. Technol. Today 1998; 1: 328-335
7. Hill JM, Callaghan RJ, Hobden JA, Kaufman E., controlled collagen shield for ocular delivery in.: Mitra AK (ed), ophthalmic drug delivery systems. New york: Marcel Dekker; 1993. 261 -275.
8. Desai SD, Blanchard J. In vitro evaluation of pluronic F 127 based controlled release ocular delivery system for the pilocarpine J. Pharm Sci 1998;87: 226-230
9. Kamel Ah El. Invitro and in vivo evaluation of pluronic f 127 based ocular delivery system based on the ocular delivery system for timolol maleate. International Journal of Pharmaceuticas 2002; 241: 47-55.
10. Gurny R. Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma. Pharm. Acta. Helv. 1981;56: 130-132
11. Gurny R, Boye T, Ibrahim H. Ocular therapy with nanoparticle system for controlled drug delivery. J. Control Rel 1985; 2: 353
12. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of the oflaxin from a ph triggered insitu gelling systems. J.Control Rel 2001; 73: 205
13. Rosier A, Manuel C, Groove J, Plazonet B. Gelrite; A novel ion activated in situ gelling polymers for ophthalmic vehicles, effect on bio availability of timolol maleate. Int.J. Pharm 1989; 57: 163-168.
14. Sanzgiri YD, Maschi S,Crescenzi V,Callingaro L, Top EM, Stella VJ. Gellan based systems for ophthalmic sustained delivery of methyl prednisonolone. J. Control Rel 1993; 2:195-201.
15. Lin HR, Sung KC. Carbopol/pluronic phase change solution for the ophthalmic drug delivery. J. Control Rel 2000; 69: 379-388.
16. Ainley Wade, Paul J Weller. Benzalkonium chloride. Handbook of pharmaceutical excipients. 2 nd Ed. London: Pharmaceutical press; 1994; 27-29.
17. Ainley Wade,Paul J Weller. Sodium chloride. Handbook of pharmaceutical excipients, 2 nd Ed.London: Pharmaceutical press; 1994;439-442.
18. Alfanso R Gennaro. Ophthalmic preparation. Remington pharmaceutical sciences, 18 th Ed. Pennsylvania: Mack Publishing Co.; 1581;1990.
19. Asgar Ali, S.N Sharma. Farication of through flow apparatus for the in vitro determination of drugs from ophthalmic preparation. Indian Drugs 1991;29(4): 157-160.
20. David J Mazzo, Alice E Loper. Timolol maleate. Analytical profile of the drug substances1987;16: 641-692.
21. Bonomi L, Perfetti S, Noya E, Bellucci R, Tomazzolli L Experimental corticosteroid ocular hypertension in the rabbit. Albrecht Von Graefe ' s Arch Klin Experimental ophthalmology 1978; 209(2):73-82.
22. Drago,Emmi I, Marino V. Effect of beta blockers association with pilocarpine on rabbit intraocular pressure and heart rate. Pharmacol.1997;35: 261-275.